32
Participants
Start Date
March 9, 2012
Primary Completion Date
August 15, 2019
Study Completion Date
August 15, 2019
Chemotherapy
Undergo standard chemotherapy
Propranolol Hydrochloride
Given PO
Quality-of-Life Assessment
Ancillary studies
Therapeutic Conventional Surgery
Undergo surgical resection
M D Anderson Cancer Center, Houston
The Woman's Hospital of Texas, Houston
MD Anderson in Katy, Houston
MD Anderson in The Woodlands, The Woodlands
MD Anderson in Sugar Land, Sugar Land
Banner MD Anderson Cancer Center, Gilbert
Lyndon Baines Johnson General Hospital, Houston
National Cancer Institute (NCI)
NIH
Sprint for Life
UNKNOWN
M.D. Anderson Cancer Center
OTHER